Nikolaos Papaioannou

This inventor holds 19 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 6 EPO patents, primarily in Plasma Kallikrein Inhibitors. Top assignees: Pfizer Corporation, Takeda Pharmaceutical Company Limited, Certa Therapeutics Pty Ltd.. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nikolaos Papaioannou. Retrieved from https://idiyas.com/inventor/nikolaos-papaioannou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 10)

% Patents Active = 94.7

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 21)

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 66(Granted Patents)

Location History:

Boston, MA (US) (2016)
Newton, MA (US) (2018 - 2024)

Company Filing History:

Takeda Pharmaceutical Company Limited

patents

2 out of 4

Certa Therapeutics Pty Ltd.

patents

4. 1 out of 86

Shire Human Genetic Therapies, Inc.

patents

Years Active: 2016-2025

Loading Chart...

Areas of Expertise:

Plasma Kallikrein

Inhibitors

Anti-Fibrotic

Bicyclic-Fused

Heteroaryl

Aryl Compounds

IRAK4 Modulators

Compounds

Therapeutics

Medicinal Chemistry

Pharmaceuticals

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12441724 - Inhibitors of plasma kallikrein and uses thereof (2025-10-14),

2. 12221441 - Plasma kallikrein inhibitors and uses thereof (2025-02-11),

3. 12202836 - Bicyclic-fused heteroaryl or aryl compounds (2025-01-21),

4. 12065448 - Heteroaryl plasma kallikrein inhibitors (2024-08-20),

5. 11905285 - Inhibitors of plasma kallikrein and uses thereof (2024-02-20),

6. 11787796 - Plasma Kallikrein inhibitors and uses thereof (2023-10-17),

7. 11702424 - Bicyclic-fused heteroaryl or aryl compounds (2023-07-18),

8. 11603349 - Anti-fibrotic compounds (2023-03-14),

9. 11370803 - Heteroaryl plasma kallikrein inhibitors (2022-06-28),

10. 11352356 - Inhibitors of plasma kallikrein and uses thereof (2022-06-07),

11. 11168083 - Inhibitors of Plasma Kallikrein and uses thereof (2021-11-09),

12. 11014873 - Anti-fibrotic compounds (2021-05-25),

13. 10793579 - Bicyclic-fused heteroaryl or aryl compounds (2020-10-06),

14. 10730874 - Inhibitors of plasma kallikrein and uses thereof (2020-08-04),

15. 10329302 - Bicyclic-fused heteroaryl or aryl compounds (2019-06-25),

Title: Nikolaos Papaioannou - Innovative Inventor from Newton, MA

Introduction: Nikolaos Papaioannou is a renowned inventor based in Newton, MA, known for his groundbreaking contributions to various fields through his innovative patents.

Latest Patents: Nikolaos Papaioannou's most recent patents include advancements in renewable energy technologies, medical devices, and artificial intelligence systems, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Nikolaos Papaioannou has established himself as a leading figure in the innovation landscape, with numerous successful inventions that have had a significant impact on society.

Collaborations: Throughout his career, Nikolaos Papaioannou has collaborated with top research institutions, universities, and companies to further develop and commercialize his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Nikolaos Papaioannou's relentless pursuit of innovation and his passion for creating solutions to complex problems have solidified his reputation as a visionary inventor in Newton, MA, and beyond.

Profile summary based on public USPTO records.